# TO UPDATE THE PERFORMANCE WORK STATEMENT FOR RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TE

> **NIH NIH N02** · PATHOGENDX · 2022 · $590,553

## Abstract

With PathogenDx's solution (DetectX-Rv), over the next four months, we will deliver a 25 fold increase in test capacity for the nation without increasing  lab-real-estate footprint, without adding endless lines of testing systems that depreciate instantly, upholding the level of accurate testing needed, and a solution that can ‘flex’ to the demands of the market with the different sized SBS plates.  What we propose is quadrupling test capacity twice on the same actual test substrate ~ optimizing the same SBS plate from 12 well array slides to 96 wells ultimately to a 384 well format in less than 4 months.   Exercising this strategy will deliver 4.15M tests per month, and result in cost savings of 55% and 70% per test. As a comparison, to deploy the same capacity using qRT-PCR technology, it will cost RaDx five times as much in CapEx and three times more per test cost.

## Key facts

- **NIH application ID:** 10579806
- **Project number:** 75N92021C00001-P00004-9999-1
- **Recipient organization:** PATHOGENDX
- **Principal Investigator:** MILAN PATEL
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $590,553
- **Award type:** —
- **Project period:** 2021-02-22 → 2022-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10579806

## Citation

> US National Institutes of Health, RePORTER application 10579806, TO UPDATE THE PERFORMANCE WORK STATEMENT FOR RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TE (75N92021C00001-P00004-9999-1). Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/grant/nih/10579806. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*